Structural Formula (Esomeprazole Strontium Delayed Release Capsules 1)
Esomeprazole Strontium
Product Images NDC 65162-955
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Strontium (NDC 65162-955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure2 (Esomeprazole Strontium Delayed Release Capsules 2)
Figure3 (Esomeprazole Strontium Delayed Release Capsules 3)
Figure4 (Esomeprazole Strontium Delayed Release Capsules 4)
This text represents the results of a clinical trial on patients using either Esomeprazole Magnesium 44.6 mg, Esomeprazole Magnesium 22.3 mg or Placebo. The trial measured the effectiveness of the drugs based on the percentage of patients who were symptom-free. The results show that 100 percent of patients who took Esomeprazole Magnesium 44.6 mg were symptom-free. The percentage for those taking Esomeprazole Magnesium 22.3 mg is not available in the given text.*
Figure5 (Esomeprazole Strontium Delayed Release Capsules 5)
This is a chart representing the percentage of patients who are symptom-free of heartburn. The chart displays the results over a period of 28 days, recorded on a diary day. The medication being evaluated is either Esomeprazole Magnesium at either 44.6mg or 223mg or a placebo. The percentages show that Esomeprazole Magnesium was more effective than the placebo.*
24.65 mg 30 Ct Bottle Label (Esomeprazole Strontium Delayed Release Capsules 6)
This is a medication with NDC 65162-955-03 consisting of delayed-release capsules containing 24.65 mg of esomeprazole strontium, equivalent to 20 mg esomeprazole. The capsule should be stored at 20°to 25°C (68" to 77°), with excursions permitted to 150 30°C (59 to 86F). The medication should be kept out of reach of children, and the container should be tightly closed. The pharmacist should dispense the medication, and the usual adult dosage should be followed as per the package insert. The medication is licensed from Hanmi Pharm. Co. Ltd and distributed by Amneal Pharmaceuticals in Glasgow, KY 42141.*
49.3 mg 30 Ct Bottle Label (Esomeprazole Strontium Delayed Release Capsules 7)
NDC 65162-957-03 is a delayed-release capsule containing 49.3 mg of esomeprazole strontium, which is equivalent to 40 mg of esomeprazole. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) and should be kept away from children. The container must be tightly closed, and dispensing should be done in a tight container. The usual adult dosage should be followed as per the package insert. This product is licensed from Hanmi Pharm. Co. Ltd., Seoul, Korea, and distributed by Amneal Pharmaceuticals PCR-780-07000. The information was last updated in June 2013.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
